Brief: Mustgrow Obtains Exclusive Rights Of Streptomyces Bio-Fungicide Product Used To Treat Powdery Mildew In Cannabis Production
03/09/2019 12:14
Sept 3 (Reuters) - MustGrow Biologics Corp MGRO.CD :
* MUSTGROW OBTAINS EXCLUSIVE RIGHTS OF STREPTOMYCES
BIO-FUNGICIDE
PRODUCT USED TO TREAT POWDERY MILDEW IN CANNABIS PRODUCTION
Source text for Eikon: ID:nGNX5HdQtP
Further company coverage: MGRO.CD
(Reuters.Briefs@thomsonreuters.com)
Recent news on MustGrow Biologics
See all newsBrief: Nexusbioag And Mustgrow Biologics Announce Exclusive Marketing And Distribution Agreement In Canada
Brief: NexusBioAg, MustGrow Announce Exclusive Marketing, Distribution Deal In Canada
Brief: Mustgrow Upsizes Private Placement To $3.67 Million
Brief: Mustgrow Obtains Exclusive Rights Of Streptomyces Bio-Fungicide Product Used To Treat Powdery Mildew In Cannabis Production
Brief: MustGrow Biologics Appoints Former Altria Group Senior Executive To Board